MedTrace Logo

An Evaluation of the Safety and Efficacy of the dTMS Treatment for OCD

NCT02229903 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-07-15

No results posted yet for this study

Summary

The purpose of the study is to evaluate the safety and efficacy of the Deep TMS (DTMS) treatment in subjects with OCD. The device technology is based on the application of deep brain TMS by means of repetitive pulse trains at a predetermined frequency. The Brainsway DTMS study is a randomized, 10 week, double blind, multi-center trial comparing active DTMS treatment to sham treatment.

Conditions

  • Obsessive Compulsive Disorder

Interventions

DEVICE

Active DTMS Treatment

H-coil Deep TMS 29 TMS treatments over 6 weeks.

DEVICE

Sham Treatment

29 treatments over 6 weeks.

Sponsors & Collaborators

  • Brainsway

    lead INDUSTRY

Principal Investigators

  • Joseph Zohar, Prof · Tel Hashomer Hospital

  • Abraham Zangen, Prof · Soroka University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Max Age
68 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • United States
  • Canada
  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02229903 on ClinicalTrials.gov